Share on StockTwits

Onconova Therapeutics (NASDAQ:ONTX) shares were up 4.7% during trading on Thursday following a better than expected earnings announcement, Analyst Ratings News reports. The stock traded as high as $5.40 and last traded at $5.35, with a volume of 113,799 shares. The stock had previously closed at $5.11.

The company reported ($0.77) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.89) by $0.12.

Separately, analysts at Leerink Swann cut their price target on shares of Onconova Therapeutics from $14.00 to $12.00 in a research note on Thursday. They now have an “outperform” rating on the stock.

The stock has a 50-day moving average of $5.02 and a 200-day moving average of $6.7. The company’s market cap is $116.6 million.

Onconova Therapeutics, Inc (NASDAQ:ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.